DESCRIPTION Elliotts B ® Solution is a sterile , nonpyrogenic , isotonic solution containing no bacteriostatic preservatives .
Elliotts B Solution is a diluent for intrathecal administration of methotrexate sodium and cytarabine .
Each 10 mL of Elliotts B Solution contains : Sodium Chloride , USP 73 mg Sodium Bicarbonate , USP 19 mg Dextrose , USP 8 mg Magnesium Sulfate • 7H2O , USP 3 mg Potassium Chloride , USP 3 mg Calcium Chloride • 2H2O , USP 2 mg Sodium Phosphate , dibasic • 7H2O , USP 2 mg Water for Injection , USP qs 10 mL Concentration of Electrolytes : Sodium 149 mEq / liter Bicarbonate 22 . 6 mEq / liter Potassium 4 . 0 mEq / liter Chloride 132 mEq / liter Calcium 2 . 7 mEq / liter Sulfate 2 . 4 mEq / liter Magnesium 2 . 4 mEq / liter Phosphate 1 . 5 mEq / liter The formulae and molecular weights of the ingredients are : INGREDIENT MOLECULAR FORMULA MOLECULAR WEIGHT Sodium Chloride NaCl 58 . 44 Sodium Bicarbonate NaHCO3 84 . 01 Dextrose C6H12O6 180 . 16 Magnesium Sulfate • 7H2O Mg2SO4 • 7H2O 246 . 48 Potassium Chloride KCl 74 . 55 Calcium Chloride • 2H2O CaCl2 • 2H2O 147 . 01 Sodium Phosphate , dibasic • 7H2O Na2HPO4 • 7H2O 268 . 07 The pH of Elliotts B Solution is 6 . 0 - 7 . 5 , and the osmolarity is 288 mOsmol per liter ( calculated ) .
CLINICAL PHARMACOLOGY Elliotts B Solution provides a buffered salt solution for use as a diluent for the intrathecal administration of methotrexate sodium and cytarabine .
It has been demonstrated that Elliotts B Solution is comparable to cere brospinal fluid in pH , electrolyte composition , glucose content , and osmolarity : Comparison of Electrolyte Composition , pH and Nonelectrolytic Constituents of Elliotts B Solution and CSF Solution Na + mEq / L K + mEq / L Ca + + mEq / L Mg + + mEq / L HCO3 - mEq / L Cl - mEq / L pH Phosphorus mg / dL Glucose mg / dL Cerebrospinal Fluid 117 - 137 2 . 3 - 4 . 6 2 . 2 2 . 2 22 . 9 113 - 127 7 . 31 1 . 2 - 2 . 1 45 - 80 Elliotts B Solution 149 4 . 0 2 . 7 2 . 4 22 . 6 132 6 . 0 - 7 . 5 2 . 3 80 The approximate buffer capacity of Elliotts B Solution is 1 . 1 X 10 - 2 equivalents when the challenge solution is 0 . 01 N HCl and 7 . 8 X 10 - 3 equivalents when the challenge solution is 0 . 01 N NaOH . 1 Compatibility studies with methotrexate sodium and cytarabine indicate these drugs are physically compati ble with Elliotts B Solution .
INDICATIONS AND USAGE Elliotts B Solution is indicated as a diluent for the intrathecal administration of methotrexate sodium and cytarabine for the prevention or treatment of meningeal leukemia or lymphocytic lymphoma .
CONTRAINDICATIONS None known .
WARNINGS Intrathecal administration of drugs such as methotrexate sodium and cytarabine should be performed by per sonnel skilled in the technique of lumbar puncture under the supervision of a physician who is experienced in the use of cancer chemotherapeutic agents .
The labeling for methotrexate sodium and cytarabine should be consulted .
PRECAUTIONS General Particular attention should be taken to assure the maintenance of sterile technique throughout the procedure .
( See DOSAGE AND ADMINISTRATION . )
Carcinogenesis , Mutagenesis , Impairment of Fertility No standard mutagenicity or carcinogenicity studies have been conducted with Elliotts B Solution .
Usage in Pregnancy All components of Elliotts B Solution are normal body constituents .
Animal reproduction studies have not been conducted with Elliotts B Solution .
ADVERSE REACTIONS Adverse reactions may occur with any given intrathecal injection due to the chemotherapy or the technique of intrathecal administration .
( See product labeling for methotrexate sodium and cytarabine . )
Preservative - free methotrexate sodium and cytarabine should be used to minimize adverse reactions due to preservatives .
If an adverse reaction does occur , discontinue the administration , evaluate the patient , institute appropriate therapeutic countermeasures and , if possible , save the remainder of the unused solution ( s ) for examination .
DRUG ABUSE AND DEPENDENCE There is no potential for drug abuse or drug dependence .
OVERDOSAGE Elliotts B Solution is a diluent .
In the event of a drug , fluid or solute overload following administration , evalu ate the patient ' s condition , and institute appropriate corrective treatment .
( See product labeling for methotrexate sodium and cytarabine . )
DOSAGE AND ADMINISTRATION See product labeling for methotrexate sodium and cytarabine .
Elliotts B Solution is intended for intrathecal administration only .
Elliotts B Solution does not contain antibac terial preservatives and introduction of contaminated solutions into the cerebrospinal fluid may have extremely serious consequences .
Therefore , administration of intrathecal solutions should be accomplished as soon as possible after preparation .
A sterile filter - needle should be used to withdraw the contents of the ampule .
Intrathecal drug products should be inspected visually for particulate matter and discoloration prior to admin istration .
Preparation and Administration Precautions Elliotts B Solution is a diluent for the cytotoxic anticancer agents , methotrexate sodium and cytarabine .
Care should be exercised in the handling and preparation of infusion solutions with these products .
( See product labeling for methotrexate sodium and cytarabine . )
HOW SUPPLIED NDC SIZE 55792 - 007 - 10 10 mL ampule Elliotts B Solution is available in single - use clear glass ampules , packaged 10 ampules per box .
Store at controlled room temperature , 20º - 25ºC ( 68º - 77ºF ) [ See USP ] .
Preservative Free .
Discard unused portion .
Use only if solution is clear and ampule is intact .
Distributed by : Lukare Medical , LLC Scotch Plains , NJ 07076 1 - 855 - 752 - 9317 www . elliottsbsolution . com REFERENCES : 1 .
Cradock JC , et al .
Evaluation of some pharmaceutical aspects of intrathecal methotrexate sodium , cytara bine and hydrocortisone sodium succinate .
American Journal of Hospital Pharmacy ( 1978 ) ; 35 : 402 .
Rev . 10 / 2015 PACKAGING Ampule labeling : [ MULTIMEDIA ] Box labeling : [ MULTIMEDIA ] [ MULTIMEDIA ] [ MULTIMEDIA ]
